Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel antipsychotics in schizophrenia.

Ann M Mortimer1

  • 1Department of Psychiatry, University of Hull, UK.

Expert Opinion on Investigational Drugs
|April 23, 2004
PubMed
Summary

New atypical antipsychotics offer improved schizophrenia treatment with fewer side effects. Research continues into novel drug mechanisms and targets, but an ideal antipsychotic remains elusive.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Attention and executive function in people with schizophrenia: Relationship with social skills and quality of life.

International journal of psychiatry in clinical practice·2014
Same author

Current and future treatment modalities in schizophrenia: novel antipsychotic drugs and cognitive therapy.

Expert review of neurotherapeutics·2013
Same author

Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia.

Journal of neuroscience research·2011
Same author

Adding a psychosocial intervention to antipsychotic medication reduces treatment discontinuation and relapse.

Evidence-based mental health·2011
Same author

Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.

Clinical schizophrenia & related psychoses·2010
Same author

Update on the management of symptoms in schizophrenia: focus on amisulpride.

Neuropsychiatric disease and treatment·2009

Area of Science:

  • Pharmacology
  • Neuroscience
  • Psychiatry

Background:

  • Atypical antipsychotics offer alternatives to conventional treatments for schizophrenia, with reduced extrapyramidal side effects.
  • Current antipsychotic mechanisms extend beyond dopamine D2 receptor antagonism.

Purpose of the Study:

  • To review current developments in antipsychotic drug discovery.
  • To examine contemporary evidence for potential substrates and mechanisms of antipsychotic action.

Main Methods:

  • Literature review of recent advancements in antipsychotic drug discovery.
  • Analysis of contemporary evidence on drug targets and mechanisms.

Main Results:

  • Several atypical antipsychotics are available, demonstrating efficacy comparable to conventional treatments with fewer side effects.
  • Numerous novel antipsychotic drugs are under development with diverse receptor affinities and proposed therapeutic effects.

Conclusions:

  • Despite promising developments, an ideal antipsychotic for schizophrenia treatment has not yet been achieved.
  • Significant challenges remain in schizophrenia drug treatment, requiring further research for substantial advances.

Related Experiment Videos